Use of recombinant factor VIIa in uncontrolled gastrointestinal bleeding after hematopoietic stem cell transplantation among patients with thrombocytopenia

BACKGROUND AND OBJECTIVE: Recombinant-activated factor VII (rVIIa) is a vitamin K-dependent glycoprotein that is an analog of the naturally occurring protease. It has an off-label use to control life-threatening bleeding that is refractory to other measures and was shown to decrease transfusion requ...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Yaqiong, Wu, Qian, Wu, Xiaojin, Qiu, Huiying, Sun, Aining, Ruan, Changgeng, Wu, Depei, Han, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Professional Medical Publications 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744287/
https://www.ncbi.nlm.nih.gov/pubmed/26870102
http://dx.doi.org/10.12669/pjms.316.8357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4744287/
https://www.ncbi.nlm.nih.gov/pubmed/26870102
http://dx.doi.org/10.12669/pjms.316.8357

Ejemplares similares